PROTEOMIC ANALYSIS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER LIVER RADIOEMBOLIZATION. PRELIMINARY RESULTS

被引：0
|
作者：
Inarrairaegui, M. [1 ,2 ]
Mora, M. I. [3 ]
Fernandez Ros, N. [1 ]
D'Avola, D. [1 ,2 ]
Sangro, B. [1 ,2 ]
Corrales, F. [3 ]
机构：
[1] Univ Navarra Clin, Liver Unit, Pamplona, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain
[3] CIMA, Area Terapia Genica & Hepatol, Pamplona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60714-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P552
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [21] Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment
    Kawakami, T
    Hoshida, Y
    Kanai, F
    Tanaka, Y
    Tateishi, K
    Ikenoue, T
    Obi, S
    Sato, S
    Teratani, T
    Shiina, S
    Kawabe, T
    Suzuki, T
    Hatano, N
    Taniguchi, H
    Omata, M
    PROTEOMICS, 2005, 5 (16) : 4287 - 4295
  • [22] Comparative proteomic analysis of liver regeneration-preliminary results
    Zhou Dong-Xun
    Tan Ye-Xiong
    Hu He-Ping
    Wang Hong-Yang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A210 - A210
  • [23] Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma
    Gabr, Ahmed
    Abouchaleh, Nadine
    Ali, Rehan
    Baker, Talia
    Caicedo, Juan
    Katariya, Nitin
    Abecassis, Michael
    Riaz, Ahsun
    Lewandowski, Robert J.
    Salem, Riad
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 29 (11) : 1502 - 1510
  • [24] LiMAx faciliates patient selection prior radioembolization for patients with hepatocellular carcinoma in liver cirrhosis
    Leyh, Catherine
    Heucke, Niklas
    Schotten, Clemens
    Buechter, Matthias
    Bechmann, Lars
    Wichert, Marc
    Dechene, Alexander
    Hermann, Ken
    Katsounas, Antonios
    Ozcurumez, Mustafa
    Heider, Dominik
    Sydor, Svenja
    Ludwig, Johannes M.
    Theysohn, Jens
    Damm, Robert
    Powerski, Maciej
    Pech, Maciej
    Canbay, Ali
    Weigt, Jochen
    Keitel-Anselmino, Verena
    Lange, Christian
    Best, Jan
    Manka, Paul
    JOURNAL OF HEPATOLOGY, 2022, 77 : S378 - S379
  • [25] Acute and chronic deterioration in liver function after transarterial radioembolization (TARE) in US patients (pts) with hepatocellular carcinoma (HCC)
    Miksad, Rebecca A.
    Piscaglia, Fabio
    Xia, Fang
    Fellous, Marc Mardoche
    Ogasawara, Sadahisa
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [26] Liver radioembolization for the treatment of hepatocellular carcinoma: Feasibility and antitumor effect
    Inarrairaegui, M.
    Bilbao, J. I.
    Martinez-Cuesta, A.
    Arbizu, J.
    Alegre, E.
    Herrero, J. I.
    Quiroga, J.
    Prieto, J.
    Sangro, B.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S146 - S146
  • [27] Analysis of prognostic factors in patients receiving transarterial radioembolization for unresectable hepatocellular carcinoma
    Soydal, Cigdem
    Araz, Mine
    Nak, Demet
    Akku, Pinar
    Baltacioglu, Muhammet Halil
    Bilgic, Sadik
    Kucuk, Nuriye Ozlem
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (01) : 73 - 77
  • [28] Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients
    Ye, Yunbin
    Huang, Aimin
    Huang, Chuanzhong
    Liu, Jingfeng
    Wang, Bin
    Lin, Kecan
    Chen, Qiang
    Zeng, Yongyi
    Chen, Huijing
    Tao, Xuan
    Wei, Guangya
    Wu, Yanbin
    PROTEOMICS CLINICAL APPLICATIONS, 2013, 7 (5-6) : 403 - 415
  • [29] Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases
    Olivan-Sasot, P.
    Perez-Enguix, D.
    Bello-Arques, P.
    Torres-Espallardo, I.
    Falgas-Lacueva, M.
    Yepes-Agudelo, A. M.
    Olivas-Arroyo, C.
    RADIOLOGIA, 2023, 65 (01): : 12 - 21
  • [30] Impact of treatment modalities on patients with recurrent hepatocellular carcinoma after liver transplantation: Preliminary experience
    Zhe Yang
    Shuo Wang
    Xin-Yao Tian
    Qin-Fen Xie
    Li Zhuang
    Qi-Yong Li
    Cheng-Ze Chen
    Shu-Sen Zheng
    Hepatobiliary&PancreaticDiseasesInternational, 2020, 19 (04) : 365 - 370
12345